DPP4 and asthma: In 2005, Kruschinski C et al. showed evidence that inhibition of DPP-4 could directly reduce airway inflammation in a rat asthma model, suggesting that DPP-4 inhibitors might have therapeutic benefits to the escalating burden of asthma and airway inflammation [31].